Structure via PubChem · Public domain (PubChem)
پراسوگرل
Sign in to saveAlso known as CS-747, Effient®, Efient®, Effient, Prasugrel
Prasugrel, sold under the brand names Effient and Efient, is a medication used to prevent formation of blood clots. It is a platelet inhibitor and an irreversible antagonist of P2Y12 ADP receptors and is of the thienopyridine drug class. It was developed by Daiichi Sankyo Co. and produced by Ube and marketed in the United States in cooperation with Eli Lilly and Company.
Chemical data
- Formula
- C20H20FNO3S
- Molecular weight
- 373.4 g/mol
- IUPAC name
- [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate
- SMILES
- CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4
- InChIKey
- DTGLZDAWLRGWQN-UHFFFAOYSA-N
- XLogP
- 3.6
- Polar surface area
- 74.9 Ų
- H-bond donors
- 0
- H-bond acceptors
- 6
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2009
- Admin. routes
- oral
- Indications
- Recurrent thrombophlebitis, myocardial infarction, acute coronary syndrome, heart disease
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 373.114793
- Has use
- medication
Show 6 more facts
- chemical formula
- C₂₀H₂₀FNO₃S
- canonical SMILES
- CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4
- defined daily dose
- 10
- medical condition treated
- acute coronary syndrome
- significant drug interaction
- alteplase
- Commons category
- Prasugrel
via Wikidata · CC0